ArticleArchives of medical science : AMS2023

2023: The year in cardiovascular disease - the year of new and prospective lipid lowering therapies. Can we render dyslipidemia a rare disease by 2024?

Maciej Banach et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.